{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:26:45Z","timestamp":1768634805094,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.msard.2023.104741","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T10:32:19Z","timestamp":1682937139000},"page":"104741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Risk and characteristics of attacks occurring after vaccination in patients with neuromyelitis optica spectrum disorders: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"75","author":[{"given":"Paula Baleeiro Rodrigues","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9764-3763","authenticated-orcid":false,"given":"Guilherme Diogo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2023.104741_bib0001","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nrrheum.2009.196","article-title":"Vaccines and autoimmunity","volume":"5","author":"Agmon-Levin","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.msard.2023.104741_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577236","article-title":"Risk factors of attacks in neuromyelitis optica spectrum disorders","volume":"343","author":"Akaishi","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2023.104741_bib0003","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJM199912303412707","article-title":"Molecular mimicry and autoimmunity","volume":"341","author":"Albert","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2023.104741_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103414","article-title":"Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: case report and systematic review","volume":"58","author":"Anamnart","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104741_bib0005","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1016\/j.radcr.2021.09.033","article-title":"Post COVID-19 vaccination neuromyelitis optica spectrum disorder: case report & MRI findings","volume":"16","author":"Badrawi","year":"2021","journal-title":"Radiol. Case Rep."},{"key":"10.1016\/j.msard.2023.104741_bib0006","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1590\/0004-282x-anp-2021-0162","volume":"79","author":"Becker","year":"2021","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.msard.2023.104741_bib0007","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/NRL.0000000000000420","article-title":"A case with new-onset neuromyelitis optica spectrum disorder following COVID-19 mRNA BNT162b2 vaccination","volume":"27","author":"Caliskan","year":"2022","journal-title":"Neurologist"},{"key":"10.1016\/j.msard.2023.104741_bib0008","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.clineuro.2016.03.023","article-title":"Recurrent optic neuritis and neuromyelitis optica-IgG following first and second human papillomavirus vaccinations","volume":"144","author":"Chang","year":"2016","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2023.104741_bib0009","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1007\/s10072-021-05427-4","article-title":"Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19","volume":"42","author":"Chen","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2023.104741_bib0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.msard.2019.01.052","article-title":"A case of neuromyelitis optica spectrum disorder following seasonal influenza vaccination","volume":"30","author":"Cho","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104741_bib0011","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/acn3.51404","article-title":"Mortality of neuromyelitis optica spectrum disorders in a Chinese population","volume":"8","author":"Du","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.msard.2023.104741_bib0012","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s13760-020-01396-1","article-title":"Neuromyelitis optica associated with yellow fever vaccination","volume":"121","author":"Esmanhotto","year":"2021","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.msard.2023.104741_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103321","article-title":"New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19","volume":"57","author":"Fragoso","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104741_bib0014","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1474-4422(22)00043-6","article-title":"MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19","volume":"21","author":"Francis","year":"2022","journal-title":"Lancet Neuro"},{"key":"10.1016\/j.msard.2023.104741_bib0015","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200063","article-title":"Acute inflammatory diseases of the central nervous system after SARS-CoV-2 vaccination","volume":"10","author":"Francis","year":"2023","journal-title":"Neurology - Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.msard.2023.104741_bib0016","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1111\/j.1468-1331.2010.03204.x","article-title":"Neuromyelitis optica after Japanese encephalitis vaccination","volume":"18","author":"Furukawa","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2023.104741_bib0017","article-title":"Humoral response to BNT162b2-COVID-19 or CoronaVac vaccine in NMOSD and MOGAD Patients","author":"Galleguillos","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104741_bib0018","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1055\/s-0042-1754348","article-title":"Reducing infection risk in multiple sclerosis and neuromyelitis optica spectrum disorders: a Brazilian reference center\u2019s approach","volume":"80","author":"Gomes","year":"2022","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.msard.2023.104741_bib0019","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000381826","article-title":"Seronegative neuromyelitis optica spectrum disorder following exposure to hepatitis B vaccination","volume":"7","author":"Heekin","year":"2015","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.msard.2023.104741_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103320","article-title":"COVID-19 and vaccination against SARS-CoV-2 in patients with neuromyelitis optica spectrum disorders","volume":"57","author":"Jovicevic","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104741_bib0021","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.autrev.2013.10.003","article-title":"The spectrum of post-vaccination inflammatory CNS demyelinating syndromes","volume":"13","author":"Karussis","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.msard.2023.104741_bib0022","first-page":"11","article-title":"Relapse patterns in NMOSD: evidence for earlier occurrence of optic neuritis and possible seasonal variation","author":"Khalilidehkordi","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2023.104741_bib0023","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00415-021-10780-7","article-title":"COVID-19 mRNA vaccination leading to CNS inflammation: a case series","volume":"269","author":"Khayat-Khoei","year":"2022","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2023.104741_bib0024","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/ene.12132","article-title":"Reduced antibody formation after influenza vaccination in patients with neuromyelitis optica spectrum disorder treated with rituximab","volume":"20","author":"Kim","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2023.104741_bib0025","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/1352458510383202","article-title":"Abstracts from PACTRIMS, Bali, 26-28 August 2010","volume":"16","author":"Kitazawa","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104741_bib0026","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/aws109","article-title":"Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan","volume":"135","author":"Kitley","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.msard.2023.104741_bib0027","first-page":"106","article-title":"Biphasic demyelination of the nervous system following anti-rabies vaccination","volume":"52","author":"Kulkarni","year":"2004","journal-title":"Neurol. India"},{"key":"10.1016\/j.msard.2023.104741_bib0028","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1352458510383204","article-title":"Oral presentations","volume":"16","author":"Lana-Peixoto","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2023.104741_bib0029","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1001\/jamaneurol.2014.2633","article-title":"Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases","volume":"71","author":"Langer-Gould","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2023.104741_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103189","article-title":"Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases","volume":"55","author":"Lotan","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104741_bib0031","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.msard.2018.05.003","article-title":"Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder","volume":"23","author":"Mealy","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104741_bib0032","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.phrs.2018.04.007","article-title":"Human papillomavirus vaccine and demyelinating diseases\u2014A systematic review and meta-analysis","volume":"132","author":"Mouchet","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.msard.2023.104741_bib0033","article-title":"Lupus and NMOSD: the blending of humoral autoimmunity","volume":"2020","author":"Ochi","year":"2020","journal-title":"Case Rep. Rheumatol."},{"key":"10.1016\/j.msard.2023.104741_bib0034","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"74","author":"Page","year":"2021","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.msard.2023.104741_bib0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.msard.2023.104741_bib0036","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.msard.2016.11.009","article-title":"NMOSD triggered by yellow fever vaccination - An unusual clinical presentation with segmental painful erythema","volume":"11","author":"Sch\u00f6berl","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.104741_bib0037","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1038\/s41467-022-33550-z","article-title":"Spike-antibody responses to COVID-19 vaccination by demographic and clinical factors in a prospective community cohort study","volume":"13","author":"Shrotri","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.msard.2023.104741_bib0038","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1590\/0004-282x-anp-2022-s121","article-title":"Challenges and insights in immunization in patients with demyelinating diseases: a bench-to-bedside and evidence-based review","volume":"80","author":"Silva","year":"2022","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.msard.2023.104741_bib0039","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104741_bib0040","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMra1904655","article-title":"Neuromyelitis optica spectrum disorder","volume":"387","author":"Wingerchuk","year":"2022","journal-title":"N. Engl. J. Med."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823002456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823002456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:07:31Z","timestamp":1761901651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823002456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":40,"alternative-id":["S2211034823002456"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.104741","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk and characteristics of attacks occurring after vaccination in patients with neuromyelitis optica spectrum disorders: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.104741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104741"}}